litlas
Log inCreate account

Esteban Celis

Active 1984–2023

81
Papers
20,484
Citations
73
h-index
81
i10-index

Citations

Citations per year for Esteban Celis1956: 1 citations1987: 3 citations1988: 7 citations1989: 11 citations1990: 8 citations1991: 20 citations1992: 12 citations1993: 15 citations1994: 29 citations1995: 62 citations1996: 46 citations1997: 64 citations1998: 65 citations1999: 92 citations2000: 92 citations2001: 107 citations2002: 119 citations2003: 124 citations2004: 148 citations2005: 156 citations2006: 90 citations2007: 129 citations2008: 146 citations2009: 103 citations2010: 112 citations2011: 139 citations2012: 174 citations2013: 217 citations2014: 213 citations2015: 311 citations2016: 343 citations2017: 322 citations2018: 315 citations2019: 726 citations2020: 851 citations2021: 871 citations2022: 642 citations2023: 483 citations2024: 657 citations2025: 382 citations2026: 5 citations1957–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,295 citing papers, 31.9% of this breakdownChina: 1,886 citing papers, 18.3% of this breakdownGermany: 471 citing papers, 4.6% of this breakdownUnited Kingdom: 428 citing papers, 4.1% of this breakdownJapan: 396 citing papers, 3.8% of this breakdownFrance: 369 citing papers, 3.6% of this breakdownItaly: 344 citing papers, 3.3% of this breakdownNetherlands: 250 citing papers, 2.4% of this breakdownAustralia: 203 citing papers, 2% of this breakdownCanada: 202 citing papers, 2% of this breakdownSwitzerland: 187 citing papers, 1.8% of this breakdownSouth Korea: 174 citing papers, 1.7% of this breakdown
0%31.9%Other 20.5%

Institutions

Fields

  • Medicine44.4%
  • Immunology and Microbiology35.9%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Engineering1.4%
  • Neuroscience0.8%
  • Materials Science0.2%
  • Other1%

Topics

  • Cancer Immunotherapy and Biomarkers12.4%
  • Immunotherapy and Immune Responses11.9%
  • Immune Cell Function and Interaction8.3%
  • Immune cells in cancer6.5%
  • CAR-T cell therapy research5.4%
  • T-cell and B-cell Immunology3.2%
  • Other52.3%

Coauthors

All papers

Open in search
  1. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

    Authors: Haidong Dong, Scott E. Strome, Diva R. Salomão, Hideto Tamura, Fumiya Hirano, Dallas B. Flies, Patrick C. Roche, Jun Lü, Gefeng Zhu, Koji Tamada, Vanda A. Lennon, Esteban Celis, Lieping Chen - Nature Medicine 2002 cited by 5,015

  2. Lipid accumulation and dendritic cell dysfunction in cancer

    Authors: Donna L. Herber, Wei Cao, Yulia Nefedova, Sergey V. Novitskiy, Srinivas Nagaraj, Vladimir A. Tyurin, Alex Corzo, Hyun-Il Cho, Esteban Celis, Brianna Lennox, Stella C. Knight, Tapan Padhya, Thomas V. McCaffrey, Judith C. McCaffrey, Scott Antonia, Mayer Fishman, Robert L. Ferris, Valerian E. Kagan, Dmitry I. Gabrilovich - Nature Medicine 2010 cited by 699

  3. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

    Authors: Cesar A. Corzo, Thomas Condamine, Lily Lu, Matthew J. Cotter, Je-In Youn, Pingyan Cheng, Hyun-Il Cho, Esteban Celis, David Quiceno, Tapan Padhya, Thomas V. McCaffrey, Judith C. McCaffrey, Dmitry I. Gabrilovich - The Journal of Experimental Medicine 2010 cited by 1,148

  4. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

    Authors: John D. Klement, Amy V. Paschall, Priscilla S. Redd, Mohammed L. Ibrahim, Chunwan Lu, Dafeng Yang, Esteban Celis, Scott I. Abrams, Keiko Ozato, Kebin Liu - Journal of Clinical Investigation 2018 cited by 373

  5. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer

    Authors: Filippo Veglia, Vladimir A. Tyurin, Dariush Mohammadyani, Maria Blasi, Elizabeth K. Duperret, Laxminarasimha Donthireddy, Ayumi Hashimoto, Alexandr A. Kapralov, Andrew A. Amoscato, Roberto Angelini, Sima Patel, Kevin Alicea-Torres, David B. Weiner, Maureen E. Murphy, Judith Klein‐Seetharaman, Esteban Celis, Valerian E. Kagan, Dmitry I. Gabrilovich - Nature Communications 2017 cited by 297

  6. Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

    Authors: Wei Cao, Rupal Ramakrishnan, Vladimir A. Tuyrin, Filippo Veglia, Thomas Condamine, Andrew A. Amoscato, Dariush Mohammadyani, Joseph J. Johnson, Lan Min Zhang, Judith Klein‐Seetharaman, Esteban Celis, Valerian E. Kagan, Dmitry I. Gabrilovich - The Journal of Immunology 2014 cited by 300

  7. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

    Authors: Takayuki Ohkuri, Akemi Kosaka, Kei Ishibashi, Takumi Kumai, Yui Hirata, Kenzo Ohara, Toshihiro Nagato, Kensuke Oikawa, Naoko Aoki, Yasuaki Harabuchi, Esteban Celis, Hiroya Kobayashi - Cancer Immunology Immunotherapy 2017 cited by 210

  8. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis

    Authors: Thomas Condamine, Vinit Kumar, Indu Ramachandran, Je-In Youn, Esteban Celis, Niklas K. Finnberg, Wafik S. El‐Deiry, Rafael Winograd, Robert H. Vonderheide, Nickolas R. English, Stella C. Knight, Hideo Yagita∥, Judith C. McCaffrey, Scott Antonia, Neil Hockstein, Robert L. Witt, Gregory A. Masters, Thomas Bauer, Dmitry I. Gabrilovich - Journal of Clinical Investigation 2014 cited by 368

  9. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

    Authors: Tangying Lu, Rupal Ramakrishnan, Soner Altiok, Je In Youn, Pingyan Cheng, Esteban Celis, В. М. Писарев, Simon Sherman, Michael B. Sporn, Dmitry I. Gabrilovich - Journal of Clinical Investigation 2011 cited by 361

  10. Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity

    Authors: Gang Guo, Miao Yu, Wei Xiao, Esteban Celis, Yan Cui - Cancer Research 2017 cited by 182

  11. Multiple roles for CD4+ T cells in anti‐tumor immune responses

    Authors: Richard B. Kennedy, Esteban Celis - Immunological Reviews 2008 cited by 521

  12. Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy

    Authors: Evgenii N. Tcyganov, Emilio Sanseviero, Douglas Marvel, Thomas Beer, Hsin‐Yao Tang, Peter Hembach, David W. Speicher, Qianfei Zhang, Laxminarasimha Donthireddy, Mostafa Ali, Sabina Tsyganova, В. М. Писарев, Terri M. Laufer, Dmitriy Ignatov, Soldano Ferrone, Christiane Meyer, Hélène Maby–El Hajjami, Daniel E. Speiser, Sooner Altiok, Scott Antonia, Xiaowei Xu, Wei Xu, Cathy Zheng, Lynn M. Schuchter, Ravi K. Amaravadi, Tara C. Mitchell, Giorgos C. Karakousis, Zhe Yuan, Luis J. Montaner, Esteban Celis, Dmitry I. Gabrilovich - Cancer Cell 2022 cited by 50

  13. Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells

    Authors: Srinivas Nagaraj, Adam G. Schrum, Hyun-Il Cho, Esteban Celis, Dmitry I. Gabrilovich - The Journal of Immunology 2010 cited by 420

  14. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

    Authors: Rupal Ramakrishnan, Deepak Assudani, Srinivas Nagaraj, Terri Hunter, Hyun-Il Cho, Scott Antonia, Soner Altiok, Esteban Celis, Dmitry I. Gabrilovich - Journal of Clinical Investigation 2010 cited by 459

  15. The PTEN pathway in T regs is a critical driver of the suppressive tumor microenvironment

    Authors: Madhav Sharma, Rahul Shinde, Tracy L. McGaha, Lei Huang, Rikke Holmgaard, Jedd D. Wolchok, Mario R. Mautino, Esteban Celis, Arlene H. Sharpe, Loise Francisco, Jonathan D. Powell, Hideo Yagita∥, Andrew L. Mellor, Bruce R. Blazar, David H. Munn - Science Advances 2015 cited by 169

  16. Poly-ICLC, a multi-functional immune modulator for treating cancer

    Authors: Hussein Sultan, Andres Μ. Salazar, Esteban Celis - Seminars in Immunology 2020 cited by 91

  17. Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells

    Authors: Cassian Yee, John A. Thompson, D. Byrd, Stanley R. Riddell, Patrick C. Roche, Esteban Celis, Philip D. Greenberg - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 1,205

  18. Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation

    Authors: Anja C. Roden, Michael T. Moser, Samuel D. Tri, Maria Mercader, Susan M. Kuntz, Haidong Dong, Arthur A. Hurwitz, D J McKean, Esteban Celis, Bradley C. Leibovich, James P. Allison, Eugene D. Kwon - The Journal of Immunology 2004 cited by 274

  19. Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy

    Authors: Rupal Ramakrishnan, Chun Huang, Hyun-Il Cho, Mark C. Lloyd, Joseph Johnson, Xiubao Ren, Soner Altiok, Daniel M. Sullivan, Jeffrey S. Weber, Esteban Celis, Dmitry I. Gabrilovich - Cancer Research 2012 cited by 100

  20. Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

    Authors: Karrune Woan, Maritza Lienlaf, P. Perez-Villaroel, C. Lee, Fengdong Cheng, Tessa Knox, David Woods, Kelly Barrios, John J. Powers, Eva Sahakian, Huan Wang, Jorge Canales, Danay Marante, Keiran S.M. Smalley, Joel Bergman, Edward Seto, Alan P. Kozikowski, Javier Pinilla‐Ibarz, Amod A. Sarnaik, Esteban Celis, Jeffrey S. Weber, Eduardo M. Sotomayor, Alejandro Villagra - Molecular Oncology 2015 cited by 137

  21. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

    Authors: Raziye Piranlioglu, EunMi Lee, Maria Ouzounova, Roni J. Bollag, Alicia Vinyard, Ali S. Arbab, Daniela Marasco, Mustafa Güzel, John K. Cowell, Muthushamy Thangaraju, Ahmed Chadli, Khaled A. Hassan, Max S. Wicha, Esteban Celis, Hasan Körkaya - Nature Communications 2019 cited by 107

  22. Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance

    Authors: Emily Hopewell, Weipeng Zhao, William J. Fulp, Crystina C. Bronk, Alexis S. Lopez, Michael T. Massengill, Scott Antonia, Esteban Celis, Eric B. Haura, Steven A. Enkemann, Dung Tsa Chen, Amer A. Beg - Journal of Clinical Investigation 2013 cited by 104

  23. Identification of α‐fetoprotein‐specific T‐cell receptors for hepatocellular carcinoma immunotherapy

    Authors: Wei Zhu, Yibing Peng, Lan Wang, Yuan Hong, Xiaotao Jiang, Qi Li, Heping Liu, Lei Huang, Juan Wu, Esteban Celis, Todd Merchen, Edward Kruse, Yukai He - Hepatology 2018 cited by 100

  24. Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration

    Authors: Hussein Sultan, Juan Wu, Valentyna I. Fesenkova, Aaron E. Fan, Diane Addis, Andres Μ. Salazar, Esteban Celis - Journal for ImmunoTherapy of Cancer 2020 cited by 73